-
1
-
-
41949109107
-
Mitoparan and target-selective chimeric analogues: Membrane translocation and intracellular redistribution induces mitochondrial apoptosis
-
Jones, S., Martel, C., Belzacq-Casagrande, A.S., Brenner, C., and Howl, J. (2008) Mitoparan and target-selective chimeric analogues: membrane translocation and intracellular redistribution induces mitochondrial apoptosis. Biochim. Biophys. Acta 1783, 849–863.
-
(2008)
Biochim. Biophys. Acta
, vol.1783
, pp. 849-863
-
-
Jones, S.1
Martel, C.2
Belzacq-Casagrande, A.S.3
Brenner, C.4
Howl, J.5
-
2
-
-
19344365470
-
Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide
-
Snyder, E.L., Meade, B.R., Saenz, C.C., and Dowdy, S.F. (2004) Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. PLoS Biol. 2,186–193.
-
(2004)
Plos Biol
, vol.2
, pp. 186-193
-
-
Snyder, E.L.1
Meade, B.R.2
Saenz, C.C.3
Dowdy, S.F.4
-
3
-
-
0037442965
-
Predominant suppression of apopto-some by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: Therapeutic effect of a novel polyarginine-conjugated Smac peptide
-
Yang, L., Mashima, T., Sato, S., Mochizuki, M., Yamori, T., Oh-Hara, T., and Tsuruo, T. (2003) Predominant suppression of apopto-some by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide. Cancer Res. 63, 831–837.
-
(2003)
Cancer Res
, vol.63
, pp. 831-837
-
-
Yang, L.1
Mashima, T.2
Sato, S.3
Mochizuki, M.4
Yamori, T.5
Oh-Hara, T.6
Tsuruo, T.7
-
4
-
-
58749096711
-
Anti-tumour activity mediated by protein and peptide transduction of HIV viral protein R (Vpr)
-
Muthumani, K., Lambert, V.M., Shanmugam, M., Thieu, K.P., Choo, A.Y., Chung, J.C., Satishchandran, A., Kim, J.J., Weiner, D.B., and Ugen, K.E. (2009) Anti-tumour activity mediated by protein and peptide transduction of HIV viral protein R (Vpr). Cancer Biol. Ther. 8, 180–187.
-
(2009)
Cancer Biol. Ther.
, vol.8
, pp. 180-187
-
-
Muthumani, K.1
Lambert, V.M.2
Shanmugam, M.3
Thieu, K.P.4
Choo, A.Y.5
Chung, J.C.6
Satishchandran, A.7
Kim, J.J.8
Weiner, D.B.9
Ugen, K.E.10
-
5
-
-
30444448872
-
Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell penetrating peptide
-
Lindgren, M., Rosenthal-aizman. K., Saar, K., Eiriksdottir, E., Jiang, Y., Sassian, M., Ostlund, P., Hallbrink, M., and Langel, U. (2006) Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell penetrating peptide. Biochem. Pharmacol. 71, 416–425.
-
(2006)
Biochem. Pharmacol.
, vol.71
, pp. 416-425
-
-
Lindgren, M.1
Rosenthal-Aizman, K.2
Saar, K.3
Eiriksdottir, E.4
Jiang, Y.5
Sassian, M.6
Ostlund, P.7
Hallbrink, M.8
Langel, U.9
-
6
-
-
38949104405
-
Design of a tumour-homing cell-penetrating peptide
-
Myrberg, H., Zhang, L., Mäe, M., and Langel, U. (2008) Design of a tumour-homing cell-penetrating peptide. Bioconjug. Chem. 19, 70–75.
-
(2008)
Bioconjug. Chem.
, vol.19
, pp. 70-75
-
-
Myrberg, H.1
Zhang, L.2
Mäe, M.3
Langel, U.4
-
7
-
-
28844504689
-
Prediction of cell-penetrating peptides
-
Hallbrink, M., Kilk, K., Elmquist, A., Lundberg, P., Lindgren, M., Jiang, Y., Pooga, M., Soomets, U., and Langel, U. (2005) Prediction of cell-penetrating peptides. Int. J. Pept. Res. Ther. 11, 249–259.
-
(2005)
Int. J. Pept. Res. Ther.
, vol.11
, pp. 249-259
-
-
Hallbrink, M.1
Kilk, K.2
Elmquist, A.3
Lundberg, P.4
Lindgren, M.5
Jiang, Y.6
Pooga, M.7
Soomets, U.8
Langel, U.9
-
8
-
-
57349155304
-
Proteomimetic cell penetrating peptides
-
Howl, J., and Jones, S. (2008) Proteomimetic cell penetrating peptides. Int. J. Pept. Res. Ther. 14, 359–366.
-
(2008)
Int. J. Pept. Res. Ther.
, vol.14
, pp. 359-366
-
-
Howl, J.1
Jones, S.2
-
9
-
-
0023130372
-
Evaluation of a tetrazolium-based semiauto-mated colorimetric assay: Assessment of chemosensitivity testing
-
Carmichael, J., DeGraff, W.G., Gazdar, A.F., Minna, J.D., and Mitchell, J.B. (1987) Evaluation of a tetrazolium-based semiauto-mated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 47, 936–942.
-
(1987)
Cancer Res
, vol.47
, pp. 936-942
-
-
Carmichael, J.1
Degraff, W.G.2
Gazdar, A.F.3
Minna, J.D.4
Mitchell, J.B.5
-
10
-
-
0031851545
-
False-positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by pyrocarbonate
-
Stahelin, B.J., Marti, U., Solioz, M., Zimmerman, H., and Keichen, J. (1998) False-positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by pyrocarbonate, Mol. Pathol. 51, 204–208.
-
(1998)
Mol. Pathol.
, vol.51
, pp. 204-208
-
-
Stahelin, B.J.1
Marti, U.2
Solioz, M.3
Zimmerman, H.4
Keichen, J.5
-
11
-
-
0033761093
-
False positive apoptosis signal in mouse kidney and liver detected in TUNEL assay
-
Pulkkanen, K.J., Laukkanen, M.O., Naarala, J., and Yla-Herttuala, S. (2000) False positive apoptosis signal in mouse kidney and liver detected in TUNEL assay. Apoptosis 5, 329–333.
-
(2000)
Apoptosis
, vol.5
, pp. 329-333
-
-
Pulkkanen, K.J.1
Laukkanen, M.O.2
Naarala, J.3
Yla-Herttuala, S.4
-
12
-
-
0028136653
-
Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques
-
Gold, R., Schmied, M., Giegerich, G., Breitschopf, H., Hartung, H.P., Toyka, K.V., and Lassmann, H. (1994) Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71, 219–25.
-
(1994)
Lab. Invest.
, vol.71
, pp. 219-225
-
-
Gold, R.1
Schmied, M.2
Giegerich, G.3
Breitschopf, H.4
Hartung, H.P.5
Toyka, K.V.6
Lassmann, H.7
|